The COVID-19 pandemic made it clear that we need novel solutions for monitoring patients with chronic diseases such as glaucoma. One area that is particularly ripe for disruption is perimetry testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback